A study to determine early vascular healing responses after placement of an ultrathin-strut bioresorbable-polymer sirolimus-eluting stent compared to those with a durable-polymer everolimus-eluting stent using optical coherence tomography imaging
Latest Information Update: 30 Jun 2021
At a glance
- Drugs Everolimus (Primary) ; Sirolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 30 Jun 2021 New trial record
- 29 May 2021 Primary endpoint has been met (Percentage of uncovered struts at one month) , according to Results published in the International Heart Journal
- 29 May 2021 Results published in the International Heart Journal